Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01532349 · ClinicalTrials.gov registry record · Phase 2
Vitamin D as a Modifier of Serum Hepcidin in Children With Chronic Kidney Disease
A Phase 2 study of Anemia of Chronic Kidney Disease, sponsored by Johns Hopkins University.
- Completed
- Registry status
- Phase 2
- Development phase
- 34
- Enrollment target
- 1
- Study location
NCT01532349 is a Phase 2 study of Anemia of Chronic Kidney Disease that has completed, run by Johns Hopkins University. The registered enrollment target is 34 participants, below the 653-participant average among 4 other Anemia of Chronic Kidney Disease trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01532349, a Phase 2 study of Anemia of Chronic Kidney Disease, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 34 participants
- Enrollment target
- 1
- Study location
Study Summary
This research is being done to study the effectiveness of vitamin D (cholecalciferol) to modify hepcidin levels in children with chronic kidney disease (CKD). Anemia is a common problem in children with CKD. Anemia is when the body does not have enough healthy red blood cells. Hepcidin is a protein in the blood which interferes with the body's production of red blood cells. This study will see if vitamin D lowers hepcidin levels in children and young adults with CKD. If so, it could be used as an additional treatment for anemia in these children, in addition to the current therapies already in use including iron supplements and erythropoietin. People between the ages of 1 and 21 with CKD may be considered for this study.
Conditions Studied
Interventions
- DRUG Cholecalciferol
Study Locations (1)
Maryland
- Johns Hopkins University - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2012-05 |
| Est. Completion | 2015-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01532349
The ClinicalTrials.gov registry entry for NCT01532349 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 653-participant average among 4 other Anemia of Chronic Kidney Disease trials with a reported enrollment target (95% lower). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Anemia of Chronic Kidney Disease appearing as the primary indexed condition, and to 1 intervention - of which Cholecalciferol is the first listed.
NCT01532349 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT01532349 about?
NCT01532349 is a clinical study titled "Vitamin D as a Modifier of Serum Hepcidin in Children With Chronic Kidney Disease". This research is being done to study the effectiveness of vitamin D (cholecalciferol) to modify hepcidin levels in children with chronic kidney disease (CKD). Anemia is a common problem in children with CKD. Anemia is when the body does not have enough healthy red blood cells. Hepcidin is a protein ...
What is the current status of trial NCT01532349?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 34 participants. The study started on 2012-05. Estimated completion is 2015-04.
What conditions does trial NCT01532349 study?
This clinical trial studies the following conditions: Anemia of Chronic Kidney Disease.
What interventions are being tested in trial NCT01532349?
The interventions under investigation include: Cholecalciferol (DRUG).
Who is sponsoring clinical trial NCT01532349?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01532349 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anemia of Chronic Kidney Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Study of DISC-0974 to Assess the Safety, Tolerability, PK and PD of DISC-0974 in Participants With CKD and Anemia
ACTIVE NOT RECRUITING · Phase 1
-
To Evaluate the Efficacy of Three Times Weekly (TIW) Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis
ACTIVE NOT RECRUITING · Phase 3
-
Vafseo Outcomes In-Center Experience
ACTIVE NOT RECRUITING · Phase 3
-
Iron Dosing Pilot Study Using Model Predictive Control
COMPLETED · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.